PDX models

CancerTools provides large, diverse collections of Patient–Derived Xenograft (PDX) models for breast cancer and lung cancer that are: 

• Highly valuable in recapitulating patient tumour characteristics, including intratumour heterogeneity, genomic features, metastatic patterns, and drug responses 

• Highly translatable preclinical models that can be used to more accurately test therapy efficacy and predict patient drug responses than traditional models 

• A superior choice for studying advanced cancers than traditional models that fail to accurately recapitulate metastasis 

Access our PDX model collections for your research and preclinical drug discovery from leading cancer institutes.